Literature DB >> 974006

Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.

O Fodstad, S Olsnes, A Pihl.   

Abstract

The survival time of mice after i.v. injection of the cancerostatic lectins, abrin and ricin was recorded. The LD50 dose was found to be 10-13 ng and 55-65 ng per mouse for abrin and ricin, respectively. Increasing amounts of toxin reduced the survival time, reaching a minimum of about 10 h. Lactose injected with ricin, provided partial protection against ricin, as measured by the survival time. Abrin and ricin labelled with 125I, and shown to retain their full toxic activity, were injected into mice. Most of the radioactivity found in the organs was present in the form of intact toxins, at least up to 5 h after injection. After i.v. injection the highest concentration/g tissue was found in spleen, followed by kidneys, heart, liver and thymus. The relative concentration in liver was considerably higher for ricin than for abrin. Similar results were found after i.p. injection. When lactose was administered together with ricin, almost 80% of the ricin injected was found in the liver after 30 min, compared to 48% without lactose, and the amount in other organs was concurrently reduced. The elimination of total radioactivity was much faster for ricin than abrin. The radioactivity found in the urine was largely present in non-trichloroacetic acid precipitable form, indicating that the toxins were extensively degraded before excretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974006      PMCID: PMC2025264          DOI: 10.1038/bjc.1976.187

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Rates of different steps involved in the inhibition of protein synthesis by the toxic lectins abrin and ricin.

Authors:  S Olsnes; K Sandvig; K Refsnes; A Pihl
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

2.  Isolation and properties of abrin: a toxic protein inhibiting protein synthesis. Evidence for different biological functions of its two constituent-peptide chains.

Authors:  S Olsnes; A Pihl
Journal:  Eur J Biochem       Date:  1973-05

3.  Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis.

Authors:  S Olsnes; A Pihl
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

4.  Mechanism of action of the toxic lectins abrin and ricin.

Authors:  S Olsnes; K Refsnes; A Pihl
Journal:  Nature       Date:  1974-06-14       Impact factor: 49.962

5.  Treatment of abrin and ricin with -mercaptoethanol opposite effects on their toxicity in mice and their ability to inhibit protein synthesis in a cell-free system.

Authors:  S Olsnes; A Pihl
Journal:  FEBS Lett       Date:  1972-11-15       Impact factor: 4.124

6.  Abrin and ricin: new anti-tumour substances.

Authors:  J Y Lin; K Y Tserng; C C Chen; L T Lin; T C Tung
Journal:  Nature       Date:  1970-07-18       Impact factor: 49.962

7.  Lectins from Abrus precatorius and Ricinus communis. I. Immunochemical relationships between toxins and agglutinins.

Authors:  A M Pappenheimer; S Olsnes; A A Harper
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

8.  Studies on the structure and properties of the lectins from Abrus precatorius and Ricinus communis.

Authors:  S Olsnes; K Refsnes; T B Christensen; A Pihl
Journal:  Biochim Biophys Acta       Date:  1975-09-09

9.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

10.  Action of diphtheria toxin in the guinea pig.

Authors:  J B Baseman; A M Pappenheimer; D M Gill; A A Harper
Journal:  J Exp Med       Date:  1970-12-01       Impact factor: 14.307

  10 in total
  22 in total

1.  Immunocytochemical detection of ricin. I. Preliminary immunofluorescence studies.

Authors:  H A Cmiech; M Morley; D J Gee
Journal:  Histochem J       Date:  1985-08

2.  Modification of ricin and its hepatotoxicity and activity against hepatocellular cancer in mice.

Authors:  Wen-Xue Wang; Ju-Ying Dong; Si-Yuan Zhou; Wen-Li Li; Ying Zhao
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

3.  Uptake of injected 125I-ricin by rat liver in vivo. Subcellular distribution and characterization of the internalized ligand.

Authors:  J P Frénoy; E Turpin; M Janicot; F Gehin-Fouque; B Desbuquois
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

4.  The carriage and delivery of substances to lymphatic tissues by recirculating lymphocytes. I. The concentration of ricin in lymphocyte traffic areas.

Authors:  S M Sparshott; J A Forrester; D P McIntosh; C Wood; A J Davies; W L Ford
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

5.  The effect of abrin, anti-lymphocyte globulin and their conjugates on the immune response of mice to sheep red blood cells.

Authors:  D C Edwards; A Smith; W C Ross; A J Cumber; P E Thorpe; A J Davies
Journal:  Experientia       Date:  1981-03-15

6.  Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells.

Authors:  S Magnússon; T Berg
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

7.  Immunocytochemical detection of ricin. II. Further studies using the immunoperoxidase method.

Authors:  G D Griffiths; H V Newman; D J Gee
Journal:  Histochem J       Date:  1986-04

8.  Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity.

Authors:  Thibaut Pelat; Michael Hust; Martha Hale; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  BMC Biotechnol       Date:  2009-06-30       Impact factor: 2.563

9.  Ricin toxicokinetics and its sensitive detection in mouse sera or feces using immuno-PCR.

Authors:  Xiaohua He; Stephanie McMahon; Thomas D Henderson; Stephen M Griffey; Luisa W Cheng
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

10.  Pharmacological studies of ricin in mice and humans.

Authors:  A Godal; O Fodstad; K Ingebrigtsen; A Pihl
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.